FDA Slaps Full Clinical Hold on Aardvark’s Hunger Drug for Prader-Willi Syndrome

FDA pauses Aardvark’s PWS drug trials over safety concerns; studies stop, shares fall, talks with FDA ongoing.

FDA Slaps Full Clinical Hold on Aardvark’s Hunger Drug for Prader-Willi Syndrome
Credit: Aardvark Therapeutics
Already have an account? Sign in.